Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Therapeutic Drug Monitoring|June 1, 1992
Bioavailability of labetalol in patients with end-stage renal diseaseD R Luke, W M Awni, C E Halstenson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 1, 1991
The adverse impact of cyclosporine on serum lipids in renal transplant recipientsB L Kasiske, K L Tortorice, K L Heim-Duthoy, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1994
Evaluation of two intravenous single-bolus methods for measuring effective renal plasma flowC A Hirata-Dulas, W M Awni, G R Matzke, et al.
The American Journal of Medicine|April 27, 1987
Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patientsD R Guay, W M Awni, P K Peterson, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effect of haemodialysis on the pharmacokinetics of cetirizineW M Awni, J Yeh, C E Halstenson, et al.
Therapeutic Drug Monitoring|July 1, 1990
The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipientsK L Tortorice, K L Heim-Duthoy, W M Awni, et al.
Clinical Pharmacokinetics|January 1, 1995
Pharmacokinetic interactions between zileuton and prednisoneW M Awni, J H Cavanaugh, T B Tzeng, et al.
Clinical Pharmacokinetics|January 1, 1995
Pharmacodynamic and stereoselective pharmacokinetic interactions between zileuton and warfarin in humansW M Awni, Z Hussein, G R Granneman, et al.
Pageof 7